Lv1
50 积分 2023-08-11 加入
Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer
1天前
已完结
Rapid and durable response to fifth-line lorlatinib plus olaparib in an ALK-rearranged, BRCA2-mutated metastatic lung adenocarcinoma patient with critical tracheal stenosis: a case report
5个月前
已完结
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
5个月前
已完结
Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors
5个月前
已关闭
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
6个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
7个月前
已完结
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system
7个月前
已关闭
Tumor‐infiltrating lymphocytes‐based subtypes and genomic characteristics of EBV‐associated lymphoepithelioma‐like carcinoma
7个月前
已完结
Mutation spectrum of FLT3 and significance of non‐canonical FLT3 mutations in haematological malignancy
11个月前
已完结
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
1年前
已完结
皖公网安备34019202002308
